Hill-Rom Holdings Inc. (HRC) Rating Lowered to Hold at Zacks Investment Research
Hill-Rom Holdings Inc. (NYSE:HRC) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday.
According to Zacks, “Post a promising third quarter by Hill-Rom, we are upbeat about the company to remain on a solid growth trajectory over the near term. The company’s year-over-year outcome was impressive along with record level of gross margin. Based on several positive catalysts, we expect the company to expand geographically in the coming quarters. Notably, in the last reported quarter, Hill-Rom posted strong growth in both Asia-Pacific and the U.S. While we remain impressed with the company’s increased bottom-line guidance for fiscal 2016, the revenue guidance was quite discouraging. Moreover, Hill-Rom’s persistent poor performance in the International front, especially in the Middle East and Latin America keeps us concerned. Unfortunately no near term improvement can be expected in the existing capital crunch condition that eventually led to economic and political downturns in these economies.”
Other analysts also recently issued research reports about the stock. KeyCorp reaffirmed a “buy” rating and set a $59.00 price target on shares of Hill-Rom Holdings in a report on Thursday, June 23rd. Morgan Stanley raised shares of Hill-Rom Holdings from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $54.00 to $62.00 in a report on Thursday, June 16th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $61.50.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/hill-rom-holdings-inc-hrc-rating-lowered-to-hold-at-zacks-investment-research.html
Hill-Rom Holdings (NYSE:HRC) traded down 0.394% during trading on Tuesday, reaching $59.455. 160,862 shares of the company’s stock were exchanged. The stock’s 50-day moving average is $58.05 and its 200-day moving average is $52.13. The company has a market cap of $3.89 billion, a P/E ratio of 61.231 and a beta of 1.06. Hill-Rom Holdings has a 12-month low of $42.99 and a 12-month high of $60.48.
Hill-Rom Holdings (NYSE:HRC) last announced its quarterly earnings results on Thursday, August 4th. The medical technology company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.76 by $0.05. The firm had revenue of $655.40 million for the quarter, compared to the consensus estimate of $647.75 million. Hill-Rom Holdings had a net margin of 2.47% and a return on equity of 16.62%. The business’s quarterly revenue was up 38.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.62 EPS. Analysts predict that Hill-Rom Holdings will post $3.33 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 30th. Stockholders of record on Friday, September 16th will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.14%. The ex-dividend date is Wednesday, September 14th. Hill-Rom Holdings’s dividend payout ratio (DPR) is presently 73.91%.
A number of large investors have recently added to or reduced their stakes in HRC. BlackRock Institutional Trust Company N.A. boosted its stake in Hill-Rom Holdings by 270.3% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 6,359,964 shares of the medical technology company’s stock worth $319,906,000 after buying an additional 4,642,638 shares during the last quarter. FMR LLC boosted its stake in Hill-Rom Holdings by 45.0% in the second quarter. FMR LLC now owns 5,017,977 shares of the medical technology company’s stock worth $253,157,000 after buying an additional 1,557,285 shares during the last quarter. Norges Bank purchased a new stake in Hill-Rom Holdings during the fourth quarter worth approximately $42,825,000. Highbridge Capital Management LLC purchased a new stake in Hill-Rom Holdings during the second quarter worth approximately $17,766,000. Finally, AXA boosted its stake in Hill-Rom Holdings by 13,543.5% in the first quarter. AXA now owns 313,800 shares of the medical technology company’s stock worth $15,784,000 after buying an additional 311,500 shares during the last quarter. Institutional investors own 83.11% of the company’s stock.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.
Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.